RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens
2006-01-01 Maggiolo, F; Ripamonti, D; Torti, C; Arici, C; Antinori, A; Quiros-Roldan, E; Minoli, L; Sighinolfi, L; Nasta, P; Suter, F
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy.
2019-01-01 Schultze, A; Torti, C; Cozzi-Lepri, A; Vandamme, Am; Zazzi, M; Sambatakou, H; De Luca, A; Geretti, Am; Sonnerborg, A; Ruiz, L; Monno, L; Di Giambenedetto, S; Gori, A; Lapadula, G; European Transmitted Drug Resistance collaboration, (EU-TDR)
The evolving burden of HIV infection compared with other chronic diseases in northern Italy
2011-01-01 Magoni, M; Scarcella, C; Vassallo, F; Lonati, F; Carosi, G; Castelnuovo, F; Quiros-Roldan, E; Albini, L; Gennaro, N; Bishai, D; Tramarin, A; Torti, C
The first meeting of the European Register of Cystic Echinococcosis (ERCE)
2016-01-01 Rossi, P; Tamarozzi, F; Galati, F; Pozio, E; Akhan, O; Cretu, Cm; Vutova, K; Siles-Lucas, M; Brunetti, E; Casulli, A; HERACLES extended, Network; Torti, C
The Impact of Gender and Anchor Drugs on TDF Renal Toxicity
2010-01-01 Quiros, Roldan; Maria Eugenia; Silvia Amadasi; Giuseppe Paraninfo; Ilaria Izzo; Roberto Allegri; Davide Motta; Francesca Gatti; Graziella Cristini; Giampiero Carosi; Monia Mendeni;, Torti; Torti, Carlo; Torti, C
The Incidence of AIDS-Defining Illnesses at a Current CD4 Count >= 200 Cells/mu L in the Post-Combination Antiretroviral Therapy Era
2013-01-01 Mocroft, A; Furrer, Hj; Miro, Jm; Reiss, P; Mussini, C; Kirk, O; Abgrall, S; Ayayi, S; Bartmeyer, B; Braun, D; Castagna, A; Monforte, Ad; Gazzard, B; Gutierrez, F; Hurtado, I; Jansen, K; Meyer, L; Munoz, P; Obel, N; Soler-Palacin, P; Papadopoulos, A; Raffi, F; Ramos, Jt; Rockstroh, Jk; Salmon, D; Torti, C; Warszawski, J; de Wit, S; Zangerle, R; Fabre-Colin, C; Kjaer, J; Chene, G; Grarup, J; Lundgren, Jd
The novel non-A, non-E hepatitis viruses and their pathogenic effect
2004-01-01 Quiros-Roldan, E; Torti, C; Carosi, G
The Omicron XBB.1 Variant and Its Descendants: Genomic Mutations, Rapid Dissemination and Notable Characteristics
2024-01-01 Giancotti, Raffaele; Lomoio, Ugo; Puccio, Barbara; Tradigo, Giuseppe; Vizza, Patrizia; Torti, Carlo; Veltri, Pierangelo; Guzzi, Pietro Hiram
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4(+) T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study
2014-01-01 Bellino, S; Tripiciano, A; Picconi, O; Francavilla, V; Longo, O; Sgadari, C; Paniccia, G; Arancio, A; Angarano, G; Ladisa, N; Lazzarin, A; Tambussi, G; Nozza, S; Torti, C; Foca, E; Palamara, G; Latini, A; Sighinolfi, L; Mazzotta, F; Di Pietro, M; Di Perri, G; Bonora, S; Mercurio, Vs; Mussini, C; Gori, A; Galli, M; Monini, P; Cafaro, A; Ensoli, F; Ensoli, B
The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients
2003-01-01 Gilleece Y; TORTI, ; Torti, Carlo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens | 1-gen-2006 | Maggiolo, F; Ripamonti, D; Torti, C; Arici, C; Antinori, A; Quiros-Roldan, E; Minoli, L; Sighinolfi, L; Nasta, P; Suter, F | |
| The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy. | 1-gen-2019 | Schultze, A; Torti, C; Cozzi-Lepri, A; Vandamme, Am; Zazzi, M; Sambatakou, H; De Luca, A; Geretti, Am; Sonnerborg, A; Ruiz, L; Monno, L; Di Giambenedetto, S; Gori, A; Lapadula, G; European Transmitted Drug Resistance collaboration, (EU-TDR) | |
| The evolving burden of HIV infection compared with other chronic diseases in northern Italy | 1-gen-2011 | Magoni, M; Scarcella, C; Vassallo, F; Lonati, F; Carosi, G; Castelnuovo, F; Quiros-Roldan, E; Albini, L; Gennaro, N; Bishai, D; Tramarin, A; Torti, C | |
| The first meeting of the European Register of Cystic Echinococcosis (ERCE) | 1-gen-2016 | Rossi, P; Tamarozzi, F; Galati, F; Pozio, E; Akhan, O; Cretu, Cm; Vutova, K; Siles-Lucas, M; Brunetti, E; Casulli, A; HERACLES extended, Network; Torti, C | |
| The Impact of Gender and Anchor Drugs on TDF Renal Toxicity | 1-gen-2010 | Quiros, Roldan; Maria Eugenia; Silvia Amadasi; Giuseppe Paraninfo; Ilaria Izzo; Roberto Allegri; Davide Motta; Francesca Gatti; Graziella Cristini; Giampiero Carosi; Monia Mendeni;, Torti; Torti, Carlo; Torti, C | |
| The Incidence of AIDS-Defining Illnesses at a Current CD4 Count >= 200 Cells/mu L in the Post-Combination Antiretroviral Therapy Era | 1-gen-2013 | Mocroft, A; Furrer, Hj; Miro, Jm; Reiss, P; Mussini, C; Kirk, O; Abgrall, S; Ayayi, S; Bartmeyer, B; Braun, D; Castagna, A; Monforte, Ad; Gazzard, B; Gutierrez, F; Hurtado, I; Jansen, K; Meyer, L; Munoz, P; Obel, N; Soler-Palacin, P; Papadopoulos, A; Raffi, F; Ramos, Jt; Rockstroh, Jk; Salmon, D; Torti, C; Warszawski, J; de Wit, S; Zangerle, R; Fabre-Colin, C; Kjaer, J; Chene, G; Grarup, J; Lundgren, Jd | |
| The novel non-A, non-E hepatitis viruses and their pathogenic effect | 1-gen-2004 | Quiros-Roldan, E; Torti, C; Carosi, G | |
| The Omicron XBB.1 Variant and Its Descendants: Genomic Mutations, Rapid Dissemination and Notable Characteristics | 1-gen-2024 | Giancotti, Raffaele; Lomoio, Ugo; Puccio, Barbara; Tradigo, Giuseppe; Vizza, Patrizia; Torti, Carlo; Veltri, Pierangelo; Guzzi, Pietro Hiram | |
| The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4(+) T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study | 1-gen-2014 | Bellino, S; Tripiciano, A; Picconi, O; Francavilla, V; Longo, O; Sgadari, C; Paniccia, G; Arancio, A; Angarano, G; Ladisa, N; Lazzarin, A; Tambussi, G; Nozza, S; Torti, C; Foca, E; Palamara, G; Latini, A; Sighinolfi, L; Mazzotta, F; Di Pietro, M; Di Perri, G; Bonora, S; Mercurio, Vs; Mussini, C; Gori, A; Galli, M; Monini, P; Cafaro, A; Ensoli, F; Ensoli, B | |
| The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients | 1-gen-2003 | Gilleece Y; TORTI, ; Torti, Carlo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 336
- 1 Contributo su Rivista::1.1 Arti... 334
- 1 Contributo su Rivista::1.2 Rece... 1
- 1 Contributo su Rivista::1.5 Abst... 1
Data di pubblicazione
- In corso di stampa 1
- 2020 - 2024 59
- 2010 - 2019 150
- 2000 - 2009 108
- 1990 - 1999 17
- 1986 - 1989 1
Rivista
- BMC INFECTIOUS DISEASES 19
- JOURNAL OF ACQUIRED IMMUNE DEFICI... 14
- JOURNAL OF ANTIMICROBIAL CHEMOTHE... 12
- AIDS 11
- ANTIVIRAL THERAPY 11
- CLINICAL INFECTIOUS DISEASES 11
- HIV MEDICINE 10
- NEW MICROBIOLOGICA 8
- THE JOURNAL OF INFECTIOUS DISEASES 8
- INFECTION 7
Keyword
- COVID-19 19
- SARS-CoV-2 16
- Humans 12
- HIV 9
- Aged 5
- HAART 5
- 80 and over 4
- NGS 4
- Retrospective Studies 4
- Electronic health records 3
Lingua
- eng 189
- ita 7
- spa 3
Accesso al fulltext
- no fulltext 336